ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Symeres, a Dutch contract research organization (CRO) serving the drug industry, has acquired Organix, a Massachusetts-based organic chemistry CRO with a focus on lipids. Symeres says Organix has annual sales of over $10 million and about 45 employees, most of whom are PhD chemists. Symeres says the purchase will take its annual sales to about $95 million and provide its first outpost in the US, where it generates close to half its revenues.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X